Unknown PHASE2 INTERVENTIONAL 2-arm NCT03060655

Study of PLGA-Mg Material in Clinical Orthopedics

Randomized, Double Blind Trial of Study of PLGA-Mg Material in Clinical Orthopedics

Sponsor: Hebei Medical University Third Hospital

Interventions PLGA-Mg material titanium alloy

Updated 6 times since 2017 Last updated: Feb 21, 2017 Started: Aug 31, 2016 Primary completion: Feb 28, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Fracture Dislocation, this trial is ongoing. The trial is conducted by Hebei Medical University Third Hospital and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Feb 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Mar 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebei Medical University Third Hospital

Data source: Hebei Medical University Third Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China